Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition

Nature Neuroscience

Volumn 1, Issue 8, 1998, Pages 659-667

  Mott, David D ^a   Doherty, James J ^a   Zhang, Sunan ^a   Washburn, Mark S ^a   Fendley, Morris J ^a   Lyuboslavsky, Polina ^a   Traynelis, Stephen F ^a   Dingledine, Raymond ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; PIPERIDINE DERIVATIVE; PROTON; RECOMBINANT PROTEIN; TRAXOPRODIL;

ANIMAL; ARTICLE; DRUG ANTAGONISM; FEMALE; METABOLISM; OOCYTE; PH; XENOPUS LAEVIS;

ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HYDROGEN-ION CONCENTRATION; NEUROPROTECTIVE AGENTS; OOCYTES; PIPERIDINES; PROTONS; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; XENOPUS LAEVIS;

EID: 0032234177     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/3661     Document Type: Article

References (48)

1. Choi, D. W. Excitotoxic cell death. J. Neurobiol. 23, 1261-1276 (1992).
2. Dingledine, R., McBain, C. J. & McNamara, J. O. Excitatory amino acid receptors in epilepsy. Trends Pharmacol. Sci. 11, 334-338 (1990).
3. Meldrum, B. & Garthwaite, J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11, 379-387 (1990).
4. Giffard, R. G., Monyer, H., Christine, C. W. & Choi, D. W. Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res. 506, 339-342 (1990).
5. +. Proc. Natl. Acad. Sci. USA 87, 6445-6449 (1990).
6. Traynelis, S. F. & Cull-Candy, S. G. Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons. Nature 345, 347-350 (1990).
7. + sensitivity of excitatory amino acid receptor channels in rat cerebellar granule neurones. J. Physiol. (Lond.) 433, 727-763 (1991).
8. Vyklický, L. Jr, Vlachová, V. & Krusek, J. The effect of external pH changes on responses to excitatory amino acids in mouse hippocampal neurones. J. Physiol. (Lond.) 430, 497-517 (1990).
9. Chesler, M. & Kaila, K. Modulation of pH by neuronal activity. Trends Neurosci. 15, 396-402 (1992).
10. Siesjo, B. K. Acid-base homoeostasis in the brain: physiology, chemistry and neurochemical pathology. Prog. Brain Res. 63, 121-153 (1985).
11. +] in the hippocampus during recovery from short-term, transient ischemia. J. Cereb. Blood Flow Metab. 12, 759-772 (1992).
12. Kaku, D. A., Giffard, R. G. & Choi, D. W. Neuroprotective effects of glutamate antagonists and extracellular acidity. Science 260, 1516-1518 (1993).
13. Carter, C. J. et al. Ifenprodil and SL 82.0175 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J. Pharmacol. Exp. Ther. 247, 1222-1232 (1988).
14. Williams, K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44, 851-859 (1993).
15. Williams, K. Pharmacological properties of recombinant N-methyl-D-aspartate (NMDA) receptors containing the ε4 (NR2D) subunit. Neurosci. Lett. 184, 181-184 (1995).
16. Blahos, J. 2nd & Wenthold, R. J. Relationship between N-methyl-D-aspartate receptor NR1 splice variants and NR2 subunits. J. Biol. Chem. 271, 15669-15674 (1996).
17. Luo, J., Wang, Y., Yasuda, R. P., Dunah, A. W. & Wolfe, B. B. The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol. Pharmacol. 51, 79-86 (1997).
18. Graham, D., Darles, G. & Langer, S. Z. The neuroprotective properties of ifenprodil, a novel NMDA receptor antagonist, in neuronal cell culture toxicity studies. Eur. J. Pharmacol. 226, 373-376 (1992).
19. Gotti, B. et al. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J. Pharmacol. Exp. Ther. 247, 1211-1221 (1988).
20. Tamura, Y. et al. Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory sites of N-methyl-D-aspartate receptors in cultured cortical neurons. J. Pharmacol Exp. Ther. 265, 1017-1025 (1993).
21. Reynolds, I. J. & Miller, R. J. Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines. Mol. Pharmacol. 36, 758-765 (1989).
22. Carter, C. J., Lloyd, K. G., Żivkovic, B. & Scatton, B. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. J. Pharmacol. Exp. Ther. 253, 475-482 (1990).
23. Legendre, P. & Westbrook, G. L. Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism. Mol. Pharmacol. 40, 289-298 (1991).
24. Kew, J. N. C., Trube, G. & Kemp, J. A. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J. Physiol. (Lond.) 497, 761-772 (1996).
25. Chenard, B. L. et al. Separation of α adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds. J. Med. Chem. 34, 3085-3090 (1991).
26. 3 receptor. Neuropharmacology 34, 621-629 (1995).
27. Fischer, G. et al. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. J. Pharmacol. Exp. Ther. 283, 1285-1292 (1997).
28. Kew, J. N. C., Trube, G. & Kemp, J. A. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist. Brit. J. Pharmacol. 123, 463-472 (1998).
29. Chenard, B. L. et al. (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses. J. Med. Chem. 38, 3138-3145 (1995).
30. Williams, K., Russell, S. L., Shen, Y. M. & Molinoff, P. B. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron 10, 267-278 (1993).
31. Menniti, F. et al. CP-101,606, a potent neuroprotectant selective for forebrain neurons. Eur. J. Pharmacol. 331, 117-126 (1997).
32. Kleckner, N. W. & Dingledine, R. Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 241, 835-837 (1988).
33. Traynelis, S. F., Burgess, M. F., Zheng, F., Lyuboslavsky, P. & Powers, J. L. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J. Neurosci. 18, 6163-6175 (1998).
34. Traynelis, S. F., Hartley, M. & Heinemann, S. F. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268, 873-876 (1995).
35. Sullivan, J. M. et al. Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron 13, 929-936 (1994).
36. Williams, K., Kashiwagi, K., Fukuchi, J. & Igarashi, K. An acidic amino acid in the N-methyl-D aspartate receptor that is important for spermine stimulation. Mol. Pharmacol. 48, 1087-1097 (1995).
37. Kashiwagi, K., Fukuchi, J.-I., Chao, J., Igarashi, K. & Williams, K. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons. Mol. Pharmacol. 49, 1131-1141 (1996).
38. Pahk, A. J. & Williams, K. Influence of extracellular pH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes. Neurosci. Lett. 225, 29-32 (1997).
39. Gallagher, M. J., Huang, H., Pritchett, D. R. & Lynch, D. R. Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 271, 9603-9611 (1996).
40. Root, M. J. & MacKinnon, R. Two identical noninteracting sites in an ion channel revealed by proton transfer. Science 265, 1852-1856 (1994).
41. Davis, S. M., Albers, G. W., Diener, H.-C., Lees, K. R. & Norris, J. Termination of acute stroke studies involving selfotel treatment. Lancet 349, 32 (1997).
42. Lees, K. R. Cerestat and other NMDA antagonists in ischemic stroke. Neurology 49, S66-S69 (1997).
43. 2+ channels and in gerbil global cerebral ischemia. Eur. J. Pharmacol. 299, 103-112 (1996).
44. 2+ channels are insensitive to eliprodil in rat cultured cerebellar neurons. Eur J. Pharmacol. 323, 277-281 (1997).
45. A receptors in acutely isolated pyramidal neurons of rat hippocampus. Neuropharmacology 35, 1279-1288 (1996).
46. Traynelis, S. F. in pH and Brain Function (eds Kaila, K. & Ransom, B. R.) 407-437 (Wiley-Liss, New York, 1998).
47. Dingledine, R., Hume, R. I. & Heinemann, S. F. Structural determinants of barium permeation and rectification in non-NMDA glutamate receptor channels. J. Neurosci. 12, 4080-4087 (1992).
48. Hoch, D. B. & Dingledine, R. GABAergic neurons in rat hippocampal culture. Dev. Brain Res. 25, 53-64 (1986).